Telix Pharmaceuticals | TLX - سرمایه عادی

قیمت سهام
13.89
تغییر روزانه
0.31 2.28%
ماهیانه
36.18%
سالیانه
-43.12%
Q2 پیش بینی
12.67




سرمایه عادی تغییر دادن تاریخ
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesoblast USD 1.29B 8.58M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
Polynovo AUD 690.84M 991 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.66M 279.42K 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12